Literature DB >> 27693070

Is There a Role for Intravenous Subdissociative-Dose Ketamine Administered as an Adjunct to Opioids or as a Single Agent for Acute Pain Management in the Emergency Department?

Sergey Motov1, Steven Rosenbaum2, Gary M Vilke3, Yuko Nakajima3.   

Abstract

BACKGROUND: Whether acute or chronic, emergency physicians frequently encounter patients reporting pain. It is the responsibility of the emergency physician to assess and evaluate, and if appropriate, safely and effectively reduce pain. Recently, analgesics other than opioids are being considered in an effort to provide safe alternatives for pain management in the emergency department (ED). Opioids have significant adverse effects such as respiratory depression, hypotension, and sedation, to say nothing of their potential for abuse. Although ketamine has long been used in the ED for procedural sedation and rapid sequence intubation, it is used infrequently for analgesia. Recent evidence suggests that ketamine use in subdissociative doses proves to be effective for pain control and serves as a feasible alternative to traditional opioids. This paper evaluates ketamine's analgesic effectiveness and safety in the ED.
METHODS: This is a literature review of randomized controlled trials, systematic reviews, meta-analyses, and observational studies evaluating ketamine for pain control in the ED setting. Based on these search parameters, eight studies were included in the final analysis and graded based on the American Academy of Emergency Medicine Clinical Practice Committee manuscript review process.
RESULTS: A total of eight papers were reviewed in detail and graded. Recommendations were given based upon this review process.
CONCLUSIONS: Subdissociative-dose ketamine (low-dose ketamine) is effective and safe to use alone or in combination with opioid analgesics for the treatment of acute pain in the ED. Its use is associated with higher rates of minor, but well-tolerated adverse side effects. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  analgesia; low-dose ketamine; subdissociative-dose ketamine

Mesh:

Substances:

Year:  2016        PMID: 27693070     DOI: 10.1016/j.jemermed.2016.07.087

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  5 in total

Review 1.  A Review of Current and Emerging Approaches to Pain Management in the Emergency Department.

Authors:  Knox H Todd
Journal:  Pain Ther       Date:  2017-11-10

Review 2.  Efficacy of ketamine in the treatment of migraines and other unspecified primary headache disorders compared to placebo and other interventions: a systematic review.

Authors:  Neysan Chah; Mike Jones; Steve Milord; Kamal Al-Eryani; Reyes Enciso
Journal:  J Dent Anesth Pain Med       Date:  2021-10-01

3.  Low-Dose Ketamine Infusion Versus Morphine Infusion During Abdominoplasty to Change the Postoperative Pain Profile.

Authors:  Hassan Ali; Ahmed Abdelaziz Ismail; Amr Samir Wahdan
Journal:  Anesth Pain Med       Date:  2020-12-19

4.  Is intravenously administered, subdissociative-dose KETAmine non-inferior to MORPHine for prehospital analgesia (the KETAMORPH study): study protocol for a randomized controlled trial.

Authors:  Clément Le Cornec; Said Lariby; Vivien Brenckmann; Jean Benoit Hardouin; Claude Ecoffey; Marion Le Pottier; Philippe Fradin; Hélène Broch; Amine Kabbaj; Yannick Auffret; Florence Deciron; Céline Longo; François Javaudin; Quentin Le Bastard; Joël Jenvrin; Emmanuel Montassier
Journal:  Trials       Date:  2018-05-02       Impact factor: 2.279

Review 5.  Ketamine for pain.

Authors:  Kelly Jonkman; Albert Dahan; Tine van de Donk; Leon Aarts; Marieke Niesters; Monique van Velzen
Journal:  F1000Res       Date:  2017-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.